Suppr超能文献

从首个选择性非肽 AT(2)受体激动剂到结构相关的拮抗剂。

From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.

机构信息

Department of Medicinal Chemistry, BMC, Uppsala University, P.O. Box 574, SE-751 23 Uppsala, Sweden.

出版信息

J Med Chem. 2012 Mar 8;55(5):2265-78. doi: 10.1021/jm2015099. Epub 2012 Feb 22.

Abstract

A para substitution pattern of the phenyl ring is a characteristic feature of the first reported selective AT(2) receptor agonist M024/C21 (1) and all the nonpeptidic AT(2) receptor agonists described so far. Two series of compounds structurally related to 1 but with a meta substitution pattern have now been synthesized and biologically evaluated for their affinity to the AT(1) and AT(2) receptors. A high AT(2)/AT(1) receptor selectivity was obtained with all 41 compounds synthesized, and the majority exhibited K(i) ranging from 2 to 100 nM. Five compounds were evaluated for their functional activity at the AT(2) receptor, applying a neurite outgrowth assay in NG108-15 cells. Notably, four of the five compounds, with representatives from both series, acted as potent AT(2) receptor antagonists. These compounds were found to be considerably more effective than PD 123,319, the standard AT(2) receptor antagonist used in most laboratories. No AT(2) receptor antagonists were previously reported among the derivatives with a para substitution pattern. Hence, by a minor modification of the agonist 1 it could be transformed into the antagonist, compound 38. These compounds should serve as valuable tools in the assessment of the role of the AT(2) receptor in more complex physiological models.

摘要

芳环的对位取代模式是首例报道的选择性 AT(2) 受体激动剂 M024/C21(1)和迄今为止所有非肽类 AT(2) 受体激动剂的特征。现在已经合成了两个与 1 结构相关但具有间位取代模式的化合物系列,并对它们与 AT(1)和 AT(2)受体的亲和力进行了生物评价。所有合成的 41 种化合物均表现出高 AT(2)/AT(1)受体选择性,其中大多数的 K(i)值在 2 至 100 nM 之间。对这 5 种化合物在 AT(2)受体上的功能活性进行了评估,在 NG108-15 细胞中应用神经突生长测定法。值得注意的是,这 5 种化合物中的 4 种,来自两个系列的代表,均作为有效的 AT(2)受体拮抗剂。这些化合物的效力明显高于 PD 123,319,这是大多数实验室中使用的标准 AT(2)受体拮抗剂。以前在具有对位取代模式的衍生物中没有报道过 AT(2)受体拮抗剂。因此,通过对激动剂 1 的微小修饰,可以将其转化为拮抗剂化合物 38。这些化合物应作为评估 AT(2)受体在更复杂生理模型中作用的有价值的工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验